Aklief

Chemical Nametrifarotene
Dosage FormCream (topical; 0.005%)
Drug ClassMiscellaneous
SystemSkin
CompanyGalderma
Approval Year2019

Indication

  • Aklief is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Last updated on 10/14/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Aklief (trifarotene) Prescribing Information 2019Galderma
Document TitleYearSource
Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. 2019Journal of the American Academy of Dermatology